[The development of experimental amyloidosis after the use of heparin, chondroitin sulfate and hyaluronidase].
D000686:Amyloidosis / Q000139:chemically induced* / Q000473:pathology; D000818:Animals; D002807:Chondroitin / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006818:Hyalin; D006821:Hyaluronoglucosaminidase / Q000009:adverse effects*; D007678:Kidney Glomerulus / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008198:Lymph Nodes / Q000187:drug effects; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D012157:Mononuclear Phagocyte System / Q000187:drug effects; D012313:RNA / Q000378:metabolism; D013154:Spleen / Q000187:drug effects / Q000473:pathology
D012313:RNA; D006493:Heparin; D002807:Chondroitin; D006821:Hyaluronoglucosaminidase
Die Entwicklung der experimentellen Amyloidose nach Anwendung von Heparin, Chondroitinsulfat und Hyaluronidase.